Generic Drugs and Biosimilars Secure Big Savings for U.S. Patients

In 2019, generic medicines saved America’s patients $313 billion and nearly $2.2 trillion in the last decade. Biosimilar medicines also saved $2.2 billion and $4.5 billion over the past 10 years. The availability of safe, effective and affordable generics and biosimilars secures tremendous access and savings for America’s patients throughout the COVID-19 pandemic.

Some key figures:

  • In 2019, generic medicines fill nine out of every ten U.S. prescriptions, but account for only 20% of all drug spending.
  • 92% of generic prescriptions are filled at $20 or less.
  • Biosimilars are projected to save America tens of billions of dollars over the next decade.

Download Fact Sheet

2020 Access & Savings Report

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.